妊娠中の妊娠中の妊娠糖尿病の決定因子の将来的な研究
C G Solomon1, W C Willett, V J Carey
1Section for Clinical Epidemiology, Division of General Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Mass, USA.
JAMA
|October 7, 1997
まとめ
妊娠中糖尿病 (GDM) のリスクは,母親の年齢,糖尿病の家族歴,より高いBMI,体重増加,喫煙によって増加します. これらの要因を特定することは,妊娠前にGDMの予防に役立ちます.
科学分野:
- 産婦人科と産婦人科を担当しています.
- エンドクリノロジー エンドクリノロジー
- エピデミオロジー エピデミオロジー
背景:
- 妊娠中糖尿病 (GDM) は,妊娠の3〜5%に影響します.
- GDMの危険因子を特定することは,予防戦略を策定する上で極めて重要です.
研究 の 目的:
- 非インスリン依存性糖尿病のリスク要因がGDMのマーカーであるかどうかを判断する.
- ライフスタイルと人口統計的要因とGDMリスクとの関連性を評価する.
主な方法:
- 看護師の健康研究IIの女性14,613人を対象とした前向きなコホート研究.
- 医療記録のレビューによって検証された自己報告されたGDM診断.
- 年齢,BMI,その他のリスク要因をコントロールする多変量分析.
主要な成果:
- GDMのリスクは,母親の年齢,糖尿病の家族歴,妊娠前のBMIの高さ (25-29.9 kg/m2および≥30 kg/m2) に伴い,有意に増加しました.
- また,早期成人期におけるより大きな体重増加,非白人の民族,および現在の喫煙でリスクの増加が観察されました.
- 激しい運動は,GDMリスクの非有意な減少を示しました.
結論:
- 先進的な母性年齢,糖尿病の家族歴,非白人民族,より高いBMI,成人期の早期の体重増加,喫煙は,GDMリスクの増加を予測する要因です.
- これらの発見は,高リスク妊娠を特定し,妊娠前のリスク軽減戦略を伝えるのに役立ちます.
- 大幅な体重増加や喫煙を避けるなど,ライフスタイルの変更により,GDMの発生率が低下する可能性があります.
関連する概念動画
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...


